2m 2m 2m 2m 2m 2m 2m
TRAWS PHARMA (TRAW)
NASDAQ
$1.45+$0.03 (+2.11%)
Price as of Jun 03, 2026 6:34 PM EDT- $22.1MMarket Cap
- -24.06%1-Year Change
- BiotechnologyIndustry
TRAWS PHARMA (TRAW)
$1.45+$0.03 (+2.11%)
TRAW | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.42 | ||
Change | -$0.05 (-3.40%) | ||
Open | $1.46 | ||
High | $1.46 | ||
Low | $1.40 | ||
Previous Close | $1.47 | ||
Volume | 292,317 | ||
30-Day Average Volume | 6,186,905 | ||
1-Week Change | -10.13% | ||
1-Month Change | -4.70% | ||
1-Year Change | -24.06% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 15.2M | ||
Total Assets | $8.2M | ||
Market Cap | $22.1M | ||
Enterprise Value | $19.0M | ||
Period: QTR TTM FY | |||
Revenue | $57,000.00 | ||
Net Income | -$7.1M | ||
Free Cash Flow | -$2.6M | ||
EBIT | -$7.1M | ||
EBITDA | -$7.1M | ||
Net Working Capital | -$7.5M | ||
EPS | -$0.53 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | 333 | ||
P/B | -4 | ||
P/E | -3 | ||
PEG | -0 | ||
Price/Free Cash Flow | -9 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 09/23/2024 | ||
Earnings & Revenue